Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 267

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 267
---
 and any other Class A Common Stock purchased during FutureTech’s initial
public offering in favor of the proposals being presented at the Special Meeting and, in order to induce the underwriters to executed
the underwriting agreement entered into in connection with the IPO, the Sponsor and each of the officers and directors of FutureTech
entered into agreements with FutureTech, pursuant to which each of them they agreed to waive their redemption rights with respect to
their founder shares and public shares and to vote in favor of the Business Combination. These agreements were reaffirmed in the Sponsor
Agreement. The Class A Common Stock held by the Sponsor and such other persons will be excluded from the pro rata calculation used to
determine the per-share redemption price. None of the Sponsor Persons received any consideration in exchange for waiving their redemption
rights. As of the date of this proxy statement/ prospectus, the Sponsor and FutureTech’s directors and executive officers, collectively,
own approximately 79.1% of the issued and outstanding FutureTech Common Stock.

| 135 |

The closing price
of the Class A Common Stock on [●], 2025 was $[●]. For illustrative purposes, as of [●], 2025, funds in the Trust Account
plus accrued interest thereon totaled approximately $[●] or approximately $[●] per issued and outstanding share of Class A Common
Stock.

Prior to exercising
redemption rights, FutureTech’s public stockholders should verify the market price of the Class A Common Stock as they may receive
higher proceeds from the sale of their Class A Common Stock in the public market than from exercising their redemption rights if the market
price per share is higher than the redemption price. FutureTech cannot assure its stockholders that they will be able to sell their Class
A Common Stock in the open market, even if the market price per share is higher than the redemption price stated above, as there may not
be sufficient liquidity in its securities when its stockholders wish to sell their shares.

Satisfaction of 80% Test

It is a requirement
under the Nasdaq listing requirements that any business acquired by FutureTech have a fair market value equal to at least 80% of the balance
of the funds in the Trust Account (excluding any deferred underwriting commissions) at the time of the execution of a definitive agreement
for an initial business combination. Based on the pre-Business Combination valuation of $100 million for Longevity compared to the approximately
$[●] million in the